Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 4:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Glaucoma
Interventions: iStent Infinite; Device
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 35 Years and older
Enrollment: 245 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Open Angle Glaucoma, Ocular Hypertension
Interventions: Brimonidine Tartrate Ophthalmic Suspension, Brimonidine Tartrate Ophthalmic Solution; Drug
Lead sponsor: Sun Pharma Advanced Research Company Limited; Industry
Eligibility: 2 Years and older
Enrollment: 682 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 47
States / cities: Chandler, Arizona • Prescott, Arizona • Sun City, Arizona + 37 more

Conditions: COPD, Pulmonary Hypertension
Interventions: PRX-08066; Drug
Lead sponsor: Epix Pharmaceuticals, Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension, Diabetes Mellitus
Interventions: Amlodipine, Hydrochlorothiazide (HCTZ), Aliskiren; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 860 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Intracranial Hemorrhage, Hypertensive, Craniotomy Tumor Removal Surgery
Interventions: Target SBP <160mmHg, Target SBP <140 mmHg; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Refractory Hypertension
Interventions: Reserpine; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 80 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Stroke, Hypertension, Home Blood Pressure Monitoring, Implementation Research
Interventions: Group medical visits and home blood pressure monitoring; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 35 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Cardiovascular Diseases, Hypertension, Nocturnal Blood Pressure, Natriuretic Peptides, Renin-Angiotensin-Aldosterone System
Interventions: Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet, Valsartan 80 mg Oral Tablet; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Aging, Mild Cognitive Impairment, Hypertension
Interventions: bpMedManage; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 60 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Tucson, Arizona • Champaign, Illinois

Conditions: Pulmonary Arterial Hypertension, Healthy
Interventions: Aerobic Training, Leg Training; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Prediabetic State
Interventions: Oral glucose tolerance test; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Metabolic Syndrome, Hypertension
Interventions: 14Nitrogen Sodium Nitrite; Drug
Lead sponsor: Gladwin, Mark, MD; Individual
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Hypertension
Interventions: Multilevel Hypertension Care Model; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 628 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Mild to Moderate Hypertension
Interventions: electroacupuncture; Other
Lead sponsor: University of California, Irvine; Other
Eligibility: 45 Years to 75 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Irvine, California • Orange, California

Conditions: Hypertension
Interventions: Health Literacy-focused Self-help, Delayed Intervention Control; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hydrocephalus, Idiopathic Intracranial Hypertension, Pseudotumor Cerebri
Interventions: Tympanic membrane displacement (TMD), DPOAE; Device
Lead sponsor: LifeBridge Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: Louisiana State University Health Sciences Center in New Orleans; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Gestational Diabetes, Pre-Eclampsia, Blood Pressure
Interventions: LabClasp; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Ocular Hypertension
Interventions: ST266 via Intranasal Delivery; Combination Product
Lead sponsor: Noveome Biotherapeutics, formerly Stemnion; Industry
Eligibility: 20 Years to 75 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Preeclampsia, Coagulation Disorder, Pregnancy Complications
Interventions: Thromboelastogram; Diagnostic Test
Lead sponsor: Augusta University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Physical Inactivity, Dyslipidemia, Obesity and Overweight, Hypertension, Diabetes, Health Care Delivery, Patients, Chronic Disease, Exercise, Physical Activity, Implementation Science
Interventions: Clinic Implementation Facilitation; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: Not listed
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Glaucoma, Intraocular Pressure
Interventions: Not listed
Lead sponsor: Robert Ritch, MD, LLC.; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Portopulmonary Hypertension
Interventions: Macitentan, Placebo; Drug · Other
Lead sponsor: Actelion; Industry
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 29
States / cities: Phoenix, Arizona • La Jolla, California • Los Angeles, California + 23 more

Conditions: Hypertension
Interventions: Sodium Butyrate 5 mmol, Sodium Butyrate 80 mmol; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 30 Years to 50 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Greensboro, North Carolina

Search by objective public record fields.

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Evaluation of Safety and Efficacy of PDP-716

An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus

Comparison of Post-Craniotomy Blood Pressure Targets

Mechanisms of Refractory Hypertension (Reserpine)

BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group Engagement

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

bpMedManage: Digital Technology to Support Adherence to Hypertension Medications

A Study of Pulmonary Hypertension Peripheral Limitations

Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study

Oral Nitrite in Adults With Metabolic Syndrome and Hypertension

Optimizing Care For Management Of Hard To Control Hypertension In Low-Income Patients Across Family Health Centers In New York City

Acupuncture Therapy and Hypertension

Understanding Health Care Information for African Americans With High Blood Pressure

Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement

Correlation Between Estimated Right Atrial Pressure and BNP in Pulmonary HTN (CRAB-PH)

Glucose and Blood Pressure During Pregnancy

Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects

Thromboelastogram in Postdelivery Preeclamptic Patients

Implementation Facilitation of Exercise is Medicine Greenville

Intraocular Pressure Fluctuation in Patients With Glaucoma and in Healthy Patients During Standard Yoga Positions

PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial

Gut Butyrate and Blood Pressure in African Americans